Background: Closures of atrial septal defects or a patent foramen ovale (PFO) are increasingly performed percutaneously. The experience of late migration of a new bio-absorbable device is presented here, followed by conceptual discussion.
Methods: Six months post PFO closure with a BioSTAR® device a patient presented with chest pain.